Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.

July 3rd, 2008 | by admin |

Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.

The present study aimed at evaluating the efficacy of lacosamide (0.3 to 30 mg/kg), a new anticonvulsant drug, in a model of essential tremor in comparison to the reference compounds propranolol and primidone. We observed a high tremorlytic effect of lacosamide reducing the intensity of tremors following harmaline administration in a dose-dependent manner. The higher dose also modified the latency and intensity of tremor at onset. The effect of lacosamide was equal or even superior to propranolol and primidone indicating that lacosamide may be a new antitremorgenic drug that merits further clinical investigation.

Stöhr T, Lekieffre D, Freitag J.

Schwarz Biosciences GmbH, Department of Pharmacology, Alfred-Nobel Street 10, 40789 Monheim, Germany.

Post a Comment

page 70 page 140 page 210 page 280 page 350 page 420 page 490 page 550 page 590 page 690 page 790